Inotiv (NASDAQ:NOTV) operates in the life sciences sector, offering products and services that span from discovery and preclinical research through clinical trial support. They specialize in providing comprehensive, integrated research solutions to help clients improve the efficiency and quality of their drug and medical device development efforts. Inotiv focuses on ensuring that their offerings are tailored to fit the evolving needs of the biopharmaceutical, medical device, and agrochemical industries. Their objective is to assist clients in accelerating their research and development timelines, optimizing their product development strategies, and ultimately enhancing patient care and agricultural production outcomes. With a commitment to innovation and client success, Inotiv strives to be a trusted partner in bringing novel treatments and solutions to market.